Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 23, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Radiochemotherapy for lung cancer in developing countries.

L Kepka1, F Casas, B Perin

  • 1Department of Radiation Oncology, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, ul. Roentgena 5, Warsaw, Poland. lucynak@coi.pl

Clinical Oncology (Royal College of Radiologists (Great Britain))
|May 1, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy-results from preclinical in-silico dose comparison and quality assurance.

The British journal of radiology·2026
Same author

Salvage radiotherapy after cryotherapy in prostate cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Pilot Testing and Vernacular Translation of EORTC Patient Satisfaction Questionnaire (PATSAT-C33 and OUT-PATSAT7) at a Tertiary Care Cancer Center in India.

South Asian journal of cancer·2025
Same author

Bridging Gaps in Cancer Care With Quality Indicators in Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Patient Selection and Outcomes in Reirradiation for Head and Neck Cancers: A Prospective Cohort Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer.

Exploration of targeted anti-tumor therapy·2024

Radiochemotherapy is standard for lung cancer, but data from developed nations needs adaptation for developing countries. Research into cost-effective treatments and national guidelines is crucial for equitable access.

Area of Science:

  • Oncology
  • Public Health

Background:

  • Radiochemotherapy is a standard treatment for locally advanced non-small cell lung cancer and limited small cell lung cancer.
  • Existing clinical trial data predominantly originates from developed countries, with limited high-quality research from developing nations.

Purpose of the Study:

  • To contextualize the application of developed-world radiochemotherapy data within the resource constraints and healthcare challenges of developing countries.
  • To highlight the necessity for developing countries to conduct their own clinical trials tailored to local needs.

Main Methods:

  • This overview discusses challenges in implementing existing radiochemotherapy data in resource-limited settings.
  • It emphasizes the need for research into more affordable combination therapies.

Related Experiment Videos

Last Updated: Jun 23, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Main Results:

  • Implementation of data from developed countries faces significant hurdles in developing nations.
  • There is a critical need for specific national guidelines and improved availability of radiotherapy equipment.

Conclusions:

  • Developing countries require tailored radiochemotherapy strategies, including cost-effective treatments and accessible radiotherapy.
  • Creating and adhering to national guidelines is essential for effective lung cancer management in these regions.